July 2026 in “Dermatology and Therapy” In this study, women experiencing hair thinning who consumed tailored botanical-based nutraceuticals saw significant increases in linear hair growth rate and other hair health parameters over 90 and 180 days, supporting their effectiveness across different life stages.
June 2026 in “International Journal of Homoeopathic Sciences” In this case report, a 36-year-old woman with alopecia areata experienced significant hair regrowth and reduced hair fall after 8 months of individualized homeopathic treatment combined with nutritional support, along with normalization of thyroid and ferritin levels.
May 2026 in “SKIN The Journal of Cutaneous Medicine” In this study, Xtressé™ gummies were found to be safe and well tolerated, showing potential improvement in hair density among women with non-scarring alopecia over four months, while partially benefiting those with scarring alopecia; larger trials are encouraged.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source describes New Hair4U Solution as containing Minoxidil, which is known to reduce hair thinning, stimulate inactive follicles, and improve hair density by enhancing scalp circulation and promoting stronger hair growth.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source highlights the benefits of New Hair4U Solution, containing Minoxidil, which is noted to aid in reducing hair thinning, stimulating inactive hair follicles, supporting scalp circulation, and promoting stronger hair growth and improved density.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This case report details a 28-year-old male with early-stage androgenetic alopecia who experienced significant hair density and thickness improvements following a three-month platelet-rich plasma therapy regimen, supporting its potential efficacy in similar cases.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this case report, a 28-year-old male with androgenetic alopecia experienced significant improvement in hair density and shaft thickness after a three-month platelet-rich plasma therapy regimen, supporting existing literature on PRP's efficacy for early-to-moderate hair loss.
February 2026 in “SHILAP Revista de lepidopterología” This study demonstrated that engineered exosomes loaded with growth factors, EGF and FGF, could successfully repair the hair follicle microenvironment in an androgenetic alopecia mouse model, enhancing hair growth without causing adverse immune reactions or toxicity.
January 2026 in “Dermatologic Therapy” This study found that in patients with female androgenetic alopecia, mesodermal injection of 0.5% minoxidil was more effective in increasing hair density and improving hairline height than topical 2% minoxidil, with comparable safety over 16 weeks.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this preprint, an integrative regenerative protocol involving microneedling, plant-derived exosomes, and other therapies was used to treat androgenetic alopecia in an elderly woman, resulting in improved hair density and scalp coverage.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This preprint reports meaningful improvements in hair density and scalp coverage in an elderly female with androgenetic alopecia treated through an integrative regenerative protocol, involving microneedling and plant-derived exosomes, among other non-pharmacological interventions focusing on cellular senescence pathways.
November 2025 in “Journal of Investigative Dermatology” This review highlights that alopecia areata significantly impacts mental health and finances, with patients facing depression, anxiety, and substantial out-of-pocket expenses due to limited insurance coverage.
September 2025 in “Pharmaceutics” In this study, quercetin nanocrystals stabilized with glycyrrhizic acid were developed as a new treatment strategy for androgenetic alopecia, which significantly reduced DHT levels and improved hair regrowth in a mouse model, indicating synergistic potential for clinical application.
July 2025 in “Skin Appendage Disorders” This study highlights significant psychosocial distress and access barriers faced by South Asian patients, suggesting improved provider education, broader insurance coverage, and enhanced patient assistance programs as necessary steps to achieve equitable healthcare access.
July 2025 in “International Journal of Medicine Sciences” This case study observed that an integrated treatment combining homeopathy and bioengineered hair therapy led to significant improvements in hair density, reduced hair fall, and emotional well-being for a woman with androgenetic alopecia.
May 2025 in “Frontiers in Bioengineering and Biotechnology” In this study, the researchers reported that a novel exosome-based treatment, EX104, effectively reversed hair follicle miniaturization and promoted hair growth in a mouse model of androgenetic alopecia, showing results comparable to minoxidil and surpassing it in stimulating capillary growth and follicular proliferation.
March 2025 in “Plastic & Reconstructive Surgery Global Open” This study reported that participants applying topical human platelet exosome extract serum experienced significant improvements in hair volume, density, scalp coverage, and overall hair health compared to a placebo, and no adverse effects were observed.
January 2025 in “SKIN The Journal of Cutaneous Medicine” This study of baricitinib in adults with severe alopecia areata found that after initial success, 10.9% of participants lost treatment response by Week 152. Factors like longer disease duration and severe baseline symptoms were more common in those losing response.
January 2025 in “Acta Dermatovenerologica Alpina Pannonica et Adriatica” This review discusses the promising role of JAK inhibitors in managing alopecia areata, reporting significant hair regrowth and acceptable safety profiles but noting the need for further research on dosing and long-term safety.
January 2025 in “Regenerative Biomaterials” This study found that a microneedle patch with recombinant collagen XVII significantly improved hair coverage, follicle density, and angiogenesis in an androgenic alopecia mouse model, showing potential as a novel therapeutic strategy alongside established treatments like minoxidil.
October 2024 in “Journal of Cutaneous and Aesthetic Surgery” The authors suggest that during hair transplantation for hair loss, the parietal eminence area should be prioritized along with the mid-scalp to address future noticeable thinning, especially since this area often becomes more conspicuous over time.
February 2024 in “Scientific Reports” In this retrospective cohort study, 87.1% of pediatric patients with chemotherapy-induced alopecia experienced clinical improvement after treatment with minoxidil or combination therapy with CYP, with the combination therapy showing greater hair thickness and minimal adverse effects.
This study evaluated various herbal blends of powdered leaves, including Henna and Indigo, for their coloring and sensitivity reactions, finding Henna and Indigo to be effective natural colorants for achieving a reddish-brown hair color with better retention than marketed herbal hair dyes.
June 2023 in “Journal of cosmetic dermatology” This review provides dermatologists with a comprehensive overview of hair prostheses for alopecia patients, emphasizing key considerations such as hair coverage needs, material types, financial options, and adverse effects to better advise patients on suitable hair camouflage solutions.
December 2022 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses the potential benefits of using topical caffeine products for treating androgenic alopecia but reports no new clinical findings; the authors highlight caffeine's possible positive effects based on existing studies.
October 2022 in “Hair Transplantation” This source outlines techniques for hair transplant surgeons to take standardized, reproducible photographs that accurately document changes in hair coverage, enabling true comparisons and improving clinical practice with professional-quality images.
June 2022 in “Research journal of topical and cosmetic sciences” This study found that taking 500mg of Trichovitals® daily for 12 weeks was linked to significant improvements in hair thickness, reduced hair loss, and enhanced hair growth in young adults.
June 2020 in “Journal of Investigative Dermatology” This study reported that a treatment serum containing ingredient blends with panthenol, licorice extract, and red clover extract significantly improved hair volume, scalp coverage, and reduced hair breakage over 6 months in individuals with thinning or damaged hair.
January 2020 in “Journal of Cosmetics, Dermatological Sciences and Applications” In a 3-month study, over 90% of healthy women experiencing self-perceived hair thinning reported that the nutritional supplement DEEPLY ROOTED improved their hair growth, volume, and quality, without significant adverse effects.
October 2015 in “Elsevier eBooks” Minoxidil is effective for hair growth and safe for long-term use.